Tag Archives: AMGN

Top 10 Biotech Stocks To Own For 2023

Zacks Investment Research upgraded shares of CYBIN INC. (CYBN.NE) (OTCMKTS:CYBN) from a hold rating to a buy rating in a report issued on Tuesday morning, Zacks.com reports. Zacks Investment Research currently has $2.25 target price on the stock.

According to Zacks, “Cybin Inc. is a biotechnology company. It is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin Inc. is based in Toronto, Canada. “


Top 5 Biotech Stocks To Watch Right Now

On Aug. 25, shares of Alzheimer’s biotech Cassava Sciences (NASDAQ:SAVA) fell by more than 30% before recouping some of their losses. Investors had come across a citizen petition to the U.S. Food and Drug Administration (FDA) by New York-based securities litigation firm Labaton Sucharow calling for a clinical trial halt of the company’s phase 3 study for its lead Alzheimer’s drug, simufilam. Labaton Sucharow filed the petition on Aug. 18, and the FDA acknowledged the reports in the petition on Aug. 23.

There’s clearly a lot on the line for patients and investors....More>>>